Comparing Rosuvastatin and Atorvastatin for Heart Attack Treatment
Author Information
Author(s): Muacevic Alexander, Adler John R, Chaudhary Ahmed Jamal, Iqbal Sana, Khan Nisar Ahmad, Furrukh Anshaal, Bano Shah, Ali Muhammad Nasir, Ali Afaq, Khan Sajjad Ullah
Primary Institution: Detroit Medical Center (DMC) Sinai-Grace Hospital
Hypothesis
How do loading doses of rosuvastatin and atorvastatin affect TIMI flow in STEMI patients post-PCI?
Conclusion
Rosuvastatin and atorvastatin had comparable rapid post-perfusion TIMI flows in the initial PCI participants.
Supporting Evidence
- Both statins showed similar procedural success rates.
- TIMI flow grades were comparable between the two groups.
- Adverse events were similar for both atorvastatin and rosuvastatin.
- Hospital stay duration was not significantly different between groups.
- Statistical analysis was conducted by blinded interventional cardiologists.
Takeaway
This study looked at two medicines, rosuvastatin and atorvastatin, to see if they help heart attack patients get better blood flow after treatment. Both worked similarly well.
Methodology
This prospective, comparative study was conducted over one year, gathering data from patient interviews and electronic medical records for adults receiving primary PCI.
Potential Biases
Potential for selection bias due to non-randomized patient assignment.
Limitations
The study lacked randomization in patient allocation, which could introduce selection bias.
Participant Demographics
Average age was 62.4 years; 75.5% were male; common comorbidities included hypertension and diabetes.
Statistical Information
P-Value
0.284
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website